Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
- PMID: 8929413
- DOI: 10.1126/science.274.5292.1527
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
Abstract
Transporter-facilitated uptake of serotonin (5-hydroxytryptamine or 5-HT) has been implicated in anxiety in humans and animal models and is the site of action of widely used uptake-inhibiting antidepressant and antianxiety drugs. Human 5-HT transporter (5-HTT) gene transcription is modulated by a common polymorphism in its upstream regulatory region. The short variant of the polymorphism reduces the transcriptional efficiency of the 5-HTT gene promoter, resulting in decreased 5-HTT expression and 5-HT uptake in lymphoblasts. Association studies in two independent samples totaling 505 individuals revealed that the 5-HTT polymorphism accounts for 3 to 4 percent of total variation and 7 to 9 percent of inherited variance in anxiety-related personality traits in individuals as well as sibships.
Comment in
-
High anxiety.Science. 1996 Nov 29;274(5292):1483. doi: 10.1126/science.274.5292.1483. Science. 1996. PMID: 8966620 No abstract available.
Similar articles
-
Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample.Am J Med Genet. 2000 Apr 3;96(2):202-16. doi: 10.1002/(sici)1096-8628(20000403)96:2<202::aid-ajmg16>3.0.co;2-j. Am J Med Genet. 2000. PMID: 10893498
-
High anxiety.Science. 1996 Nov 29;274(5292):1483. doi: 10.1126/science.274.5292.1483. Science. 1996. PMID: 8966620 No abstract available.
-
Association between serotonin transporter gene polymorphism and anxiety-related traits.Biol Psychiatry. 1999 Feb 1;45(3):368-70. doi: 10.1016/s0006-3223(98)00090-0. Biol Psychiatry. 1999. PMID: 10023516
-
Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse.Pharmacogenomics. 2000 Aug;1(3):335-41. doi: 10.1517/14622416.1.3.335. Pharmacogenomics. 2000. PMID: 11256582 Review.
-
Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders?Biol Psychiatry. 1998 Aug 1;44(3):179-92. doi: 10.1016/s0006-3223(98)00121-8. Biol Psychiatry. 1998. PMID: 9693390 Review.
Cited by
-
Improved green and red GRAB sensors for monitoring spatiotemporal serotonin release in vivo.Nat Methods. 2024 Mar 5. doi: 10.1038/s41592-024-02188-8. Online ahead of print. Nat Methods. 2024. PMID: 38443508
-
Tailoring Type II Diabetes Treatment: Investigating the Effect of 5-HTT Polymorphisms on HbA1c Levels after Metformin Initiation.J Diabetes Res. 2024 Jan 22;2024:7922486. doi: 10.1155/2024/7922486. eCollection 2024. J Diabetes Res. 2024. PMID: 38288388 Free PMC article.
-
Migraine Comorbidities.Life (Basel). 2024 Jan 2;14(1):74. doi: 10.3390/life14010074. Life (Basel). 2024. PMID: 38255689 Free PMC article. Review.
-
Electroconvulsive therapy improves hematological inflammatory markers in bipolar disorder.Psychopharmacology (Berl). 2024 Feb;241(2):351-357. doi: 10.1007/s00213-023-06491-8. Epub 2023 Nov 24. Psychopharmacology (Berl). 2024. PMID: 37999745
-
Candidate gene-environment interactions in substance abuse: A systematic review.PLoS One. 2023 Oct 31;18(10):e0287446. doi: 10.1371/journal.pone.0287446. eCollection 2023. PLoS One. 2023. PMID: 37906564 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
